1
|
Chakroun RW, Sneider A, Anderson CF, Wang F, Wu P, Wirtz D, Cui H. Supramolecular Design of Unsymmetric Reverse Bolaamphiphiles for Cell‐Sensitive Hydrogel Degradation and Drug Release. Angew Chem Int Ed Engl 2020. [DOI: 10.1002/ange.201913087] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
Affiliation(s)
- Rami W. Chakroun
- Department of Chemical and Biomolecular Engineering Institute for NanoBiotechnology The Johns Hopkins University 3400 North Charles Street Baltimore MD 21218 USA
| | - Alexandra Sneider
- Department of Chemical and Biomolecular Engineering Institute for NanoBiotechnology The Johns Hopkins University 3400 North Charles Street Baltimore MD 21218 USA
| | - Caleb F. Anderson
- Department of Chemical and Biomolecular Engineering Institute for NanoBiotechnology The Johns Hopkins University 3400 North Charles Street Baltimore MD 21218 USA
| | - Feihu Wang
- Department of Chemical and Biomolecular Engineering Institute for NanoBiotechnology The Johns Hopkins University 3400 North Charles Street Baltimore MD 21218 USA
| | - Pei‐Hsun Wu
- Department of Chemical and Biomolecular Engineering Institute for NanoBiotechnology The Johns Hopkins University 3400 North Charles Street Baltimore MD 21218 USA
- Department of Oncology and Sidney Kimmel Comprehensive Cancer Center Johns Hopkins University School of Medicine 400 North Broadway Baltimore MD 21231 USA
| | - Denis Wirtz
- Department of Chemical and Biomolecular Engineering Institute for NanoBiotechnology The Johns Hopkins University 3400 North Charles Street Baltimore MD 21218 USA
- Department of Oncology and Sidney Kimmel Comprehensive Cancer Center Johns Hopkins University School of Medicine 400 North Broadway Baltimore MD 21231 USA
| | - Honggang Cui
- Department of Chemical and Biomolecular Engineering Institute for NanoBiotechnology The Johns Hopkins University 3400 North Charles Street Baltimore MD 21218 USA
- Department of Oncology and Sidney Kimmel Comprehensive Cancer Center Johns Hopkins University School of Medicine 400 North Broadway Baltimore MD 21231 USA
- Center for Nanomedicine The Wilmer Eye Institute Johns Hopkins University School of Medicine USA
| |
Collapse
|
2
|
Chakroun RW, Sneider A, Anderson CF, Wang F, Wu P, Wirtz D, Cui H. Supramolecular Design of Unsymmetric Reverse Bolaamphiphiles for Cell‐Sensitive Hydrogel Degradation and Drug Release. Angew Chem Int Ed Engl 2020; 59:4434-4442. [DOI: 10.1002/anie.201913087] [Citation(s) in RCA: 43] [Impact Index Per Article: 10.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/13/2019] [Revised: 12/02/2019] [Indexed: 02/04/2023]
Affiliation(s)
- Rami W. Chakroun
- Department of Chemical and Biomolecular Engineering Institute for NanoBiotechnology The Johns Hopkins University 3400 North Charles Street Baltimore MD 21218 USA
| | - Alexandra Sneider
- Department of Chemical and Biomolecular Engineering Institute for NanoBiotechnology The Johns Hopkins University 3400 North Charles Street Baltimore MD 21218 USA
| | - Caleb F. Anderson
- Department of Chemical and Biomolecular Engineering Institute for NanoBiotechnology The Johns Hopkins University 3400 North Charles Street Baltimore MD 21218 USA
| | - Feihu Wang
- Department of Chemical and Biomolecular Engineering Institute for NanoBiotechnology The Johns Hopkins University 3400 North Charles Street Baltimore MD 21218 USA
| | - Pei‐Hsun Wu
- Department of Chemical and Biomolecular Engineering Institute for NanoBiotechnology The Johns Hopkins University 3400 North Charles Street Baltimore MD 21218 USA
- Department of Oncology and Sidney Kimmel Comprehensive Cancer Center Johns Hopkins University School of Medicine 400 North Broadway Baltimore MD 21231 USA
| | - Denis Wirtz
- Department of Chemical and Biomolecular Engineering Institute for NanoBiotechnology The Johns Hopkins University 3400 North Charles Street Baltimore MD 21218 USA
- Department of Oncology and Sidney Kimmel Comprehensive Cancer Center Johns Hopkins University School of Medicine 400 North Broadway Baltimore MD 21231 USA
| | - Honggang Cui
- Department of Chemical and Biomolecular Engineering Institute for NanoBiotechnology The Johns Hopkins University 3400 North Charles Street Baltimore MD 21218 USA
- Department of Oncology and Sidney Kimmel Comprehensive Cancer Center Johns Hopkins University School of Medicine 400 North Broadway Baltimore MD 21231 USA
- Center for Nanomedicine The Wilmer Eye Institute Johns Hopkins University School of Medicine USA
| |
Collapse
|
3
|
Mura S, Fattal E, Nicolas J. From poly(alkyl cyanoacrylate) to squalene as core material for the design of nanomedicines. J Drug Target 2019; 27:470-501. [PMID: 30720372 DOI: 10.1080/1061186x.2019.1579822] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
Abstract
This review article covers the most important steps of the pioneering work of Patrick Couvreur and tries to shed light on his outstanding career that has been a source of inspiration for many decades. His discovery of biodegradable poly(alkyl cyanoacrylate) (PACA) nanoparticles (NPs) has opened large perspectives in nanomedicine. Indeed, NPs made from various types of alkyl cyanoacrylate monomers have been used in different applications, such as the treatment of intracellular infections or the treatment of multidrug resistant hepatocarcinoma. This latest application led to the Phase III clinical trial of Livatag®, a PACA nanoparticulate formulation of doxorubicin. Despite the success of PACA NPs, the development of a novel type of NP with higher drug loadings and lower burst release was tackled by the discovery of squalene-based nanomedicines where the drug is covalently linked to the lipid derivative and the resulting conjugate is self-assembled into NPs. This pioneering work was accompanied by a wide range of novel applications which mainly dealt with the management of unmet medical needs (e.g. pancreatic cancer, brain ischaemia and spinal cord injury).
Collapse
Affiliation(s)
- Simona Mura
- a Institut Galien Paris-Sud, UMR CNRS 8612, Faculté de Pharmacie, Université Paris-Sud, Université Paris-Saclay , Châtenay-Malabry , France
| | - Elias Fattal
- a Institut Galien Paris-Sud, UMR CNRS 8612, Faculté de Pharmacie, Université Paris-Sud, Université Paris-Saclay , Châtenay-Malabry , France
| | - Julien Nicolas
- a Institut Galien Paris-Sud, UMR CNRS 8612, Faculté de Pharmacie, Université Paris-Sud, Université Paris-Saclay , Châtenay-Malabry , France
| |
Collapse
|
4
|
Kanapathipillai M, Brock A, Ingber DE. Nanoparticle targeting of anti-cancer drugs that alter intracellular signaling or influence the tumor microenvironment. Adv Drug Deliv Rev 2014; 79-80:107-18. [PMID: 24819216 DOI: 10.1016/j.addr.2014.05.005] [Citation(s) in RCA: 145] [Impact Index Per Article: 14.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/02/2013] [Revised: 04/22/2014] [Accepted: 05/01/2014] [Indexed: 12/13/2022]
Abstract
Nanoparticle-based therapeutics are poised to become a leading delivery strategy for cancer treatment because they potentially offer higher selectivity, reduced toxicity, longer clearance times, and increased efficacy compared to conventional systemic therapeutic approaches. This article reviews existing nanoparticle technologies and methods that are used to target drugs to treat cancer by altering signal transduction or modulating the tumor microenvironment. We also consider the implications of recent advances in the nanotherapeutics field for the future of cancer therapy.
Collapse
|
5
|
|
6
|
Emerging nanodelivery strategies of RNAi molecules for colon cancer therapy: preclinical developments. Ther Deliv 2012; 3:1117-30. [DOI: 10.4155/tde.12.89] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/21/2022] Open
Abstract
Although local colonic delivery is achievable through several strategies, colon cancer is still considered one of the leading causes of death worldwide. Failure of chemotherapeutics to exhibit efficient anticancer activity might be attributed to the development of multidrug resistance (MDR) mechanisms including the overexpression of certain oncogenes such as MDR1/P-gp. One of the major reasons for the shortcoming of P-gp inhibitors in clinic is the nonspecific distribution of them to nontarget organs, which leads to reduced elimination and increased toxicity of its substrates including anticancer agents. Numerous studies have demonstrated the effectiveness of gene-silencing approaches in reversing the P-gp-mediated MDR. However, none have reached clinical trials yet. Several drug-delivery systems have been investigated primarily to address P-gp and the observed improved anticancer efficacy suggests that nanomedicine provides new opportunities to overcome MDR in cancer. In this review, novel therapeutic strategies for colon cancer therapy will be discussed in the context of P-gp inhibition by low-molecular-weight agents and RNAi molecules.
Collapse
|
7
|
|
8
|
Dong X, Mumper RJ. Nanomedicinal strategies to treat multidrug-resistant tumors: current progress. Nanomedicine (Lond) 2010; 5:597-615. [PMID: 20528455 DOI: 10.2217/nnm.10.35] [Citation(s) in RCA: 245] [Impact Index Per Article: 17.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/06/2023] Open
Abstract
Multidrug resistance (MDR) is a major impediment to the success of cancer chemotherapy. P-glycoprotein is an important and the best-known membrane transporter involved in MDR. Several strategies have been used to address MDR, especially P-glycoprotein-mediated drug resistance in tumors. However, clinical success has been limited, largely due to issues regarding lack of efficacy and/or safety. Nanoparticles have shown the ability to target tumors based on their unique physical and biological properties. To date, nanoparticles have been investigated primarily to address P-glycoprotein and the observed improved anticancer efficacy suggests that nanomedicinal strategies provide a new opportunity to overcome MDR. This article focuses on nanotechnology-based formulations and current nanomedicine approaches to address MDR in tumors and discusses the proposed mechanisms of action.
Collapse
Affiliation(s)
- Xiaowei Dong
- Department of Pharmaceutical Sciences, College of Pharmacy, University of Kentucky, Lexington, KY 40536-0082, USA
| | | |
Collapse
|
9
|
Heidel JD, Davis ME. Clinical developments in nanotechnology for cancer therapy. Pharm Res 2010; 28:187-99. [PMID: 20549313 DOI: 10.1007/s11095-010-0178-7] [Citation(s) in RCA: 139] [Impact Index Per Article: 9.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/10/2010] [Accepted: 05/19/2010] [Indexed: 11/26/2022]
Abstract
Nanoparticle approaches to drug delivery for cancer offer exciting and potentially "game-changing" ways to improve patient care and quality of life in numerous ways, such as reducing off-target toxicities by more selectively directing drug molecules to intracellular targets of cancer cells. Here, we focus on technologies being investigated clinically and discuss numerous types of therapeutic molecules that have been incorporated within nanostructured entities such as nanoparticles. The impacts of nanostructured therapeutics on efficacy and safety, including parameters like pharmacokinetics and biodistribution, are described for several drug molecules. Additionally, we discuss recent advances in the understanding of ligand-based targeting of nanoparticles, such as on receptor avidity and selectivity.
Collapse
|
10
|
Abstract
Recent developments in nanotechnology offer researchers opportunities to significantly transform cancer therapeutics. This technology has enabled the manipulation of the biological and physicochemical properties of nanomaterials to facilitate more efficient drug targeting and delivery. Clinical investigations suggest that therapeutic nanoparticles can enhance efficacy and reduced side effects compared with conventional cancer therapeutic drugs. Encouraged by rapid and promising progress in cancer nanotechnology, researchers continue to develop novel and efficacious nanoparticles for drug delivery. The use of therapeutic nanoparticles as unique drug delivery systems will be a significant addition to current cancer therapeutics.
Collapse
Affiliation(s)
- Xu Wang
- Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA 30322, USA
| | | | | | | |
Collapse
|
11
|
|
12
|
|
13
|
Wang X, Zhang R, Wu C, Dai Y, Song M, Gutmann S, Gao F, Lv G, Li J, Li X, Guan Z, Fu D, Chen B. The application of Fe
3
O
4
nanoparticles in cancer research: A new strategy to inhibit drug resistance. J Biomed Mater Res A 2006; 80:852-60. [PMID: 17072850 DOI: 10.1002/jbm.a.30901] [Citation(s) in RCA: 76] [Impact Index Per Article: 4.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Abstract
Although much effort has been extended to the efficient cancer therapies, the drug resistance is still a major obstacle in cancer chemotherapeutic treatments. Almost 90% of the cancer therapy failure is caused by the relative problems. Recently, the application of drug coated polymer nanospheres and nanoparticles to inhibit the related drug resistance has attracted much attention. In this report, we have explored a novel strategy to inhibit the multidrug resistance of the targeted tumor cells by combining the unique properties of tetraheptylammonium capped Fe(3)O(4) magnetic nanoparticles with the drug accumulation of anticancer drug daunorubicin. Our results of confocal fluorescence and atomic force microscopy (AFM) as well as electrochemical studies demonstrate the remarkable synergistic effect of Fe(3)O(4) nanoparticles on drug uptake of daunorubicin in leukemia K562 cells. These observations indicate that the interaction between the magnetic nanoparticles Fe(3)O(4) and biologically active molecules on the membrane of leukemia cell lines may contribute to their beneficial effect on cellular uptake so that the synergistic enhanced effect of magnetic nanoparticles Fe(3)O(4) on drug uptake of drug resistance leukemia K562 cells could be observed upon application of the Fe(3)O(4) nanoparticles.
Collapse
Affiliation(s)
- Xuemei Wang
- State Key Lab of Bioelectronics, Chien-Shiung Wu Laboratory, Southeast University, Nanjing 210096, People's Republic of China.
| | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
14
|
Chatjigakis AK, Clarot I, Cardot PJP, Nowakowski R, Coleman A. REVERSED PHASE CHROMATOGRAPHIC STUDY OF THE INCLUSION SELECTIVITY OF TERPENE DERIVATIVES WITH β-CYCLODEXTRIN IN WATER/COSOLVENT MIXTURES. J LIQ CHROMATOGR R T 2006. [DOI: 10.1081/jlc-100101731] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
Affiliation(s)
- Alexis K. Chatjigakis
- a Centre d'Etudes Pharmaceutiques, Université Paris Sud , Laboratoire de Chimie Analytique et d'Electrochimie Organiques, Rue J. B. Clément, Châtenay-Malabry , 92296 , France
| | - Igor Clarot
- b Faculté de Pharmacie-Université de Limoges , Laboratoire de Chimie Analytique et Bromatologie, 2 rue du Dr Marcland, Limoges Cedex , 87025 , France
| | - Philippe J. P. Cardot
- c Faculté de Pharmacie-Université de Limoges , Laboratoire de Chimie Analytique et Bromatologie, 2 rue du Dr Marcland, Limoges Cedex , 87025 , France
| | - Robert Nowakowski
- b Faculté de Pharmacie-Université de Limoges , Laboratoire de Chimie Analytique et Bromatologie, 2 rue du Dr Marcland, Limoges Cedex , 87025 , France
| | - Anthony Coleman
- b Faculté de Pharmacie-Université de Limoges , Laboratoire de Chimie Analytique et Bromatologie, 2 rue du Dr Marcland, Limoges Cedex , 87025 , France
| |
Collapse
|
15
|
Abstract
Despite several advancements in chemotherapy, the real therapy of cancer still remains a challenge. The development of new anti-cancer drugs for the treatment of cancer has not kept pace with the progress in cancer therapy, because of the nonspecific drug distribution resulting in low tumour concentrations and systemic toxicity. The main hindrance for the distribution of anti-cancer agents to the tumour site is the highly disorganized tumour vasculature, high blood viscosity in the tumour, and high interstitial pressure within the tumour tissue. Recently, several approaches such as drug modifications and development of new carrier systems for anti-cancer agents have been attempted to enhance their tumour reach. Approaches such as drug delivery through enhanced permeability and retention (EPR) effect have resulted in a significant improvement in concentration in tumours, while approaches such as drug-carrier implants and microparticles have resulted in improvement in local chemotherapy of cancer. This review discusses different strategies employed for the delivery of anti-cancer agents to tumours, such as through EPR effect, local chemotherapeutic approaches using drug delivery systems, and special strategies such as receptor-mediated delivery, pH-based carriers, application of ultrasound and delivery to resistant tumour cells and brain using nanoparticles.
Collapse
Affiliation(s)
- L Harivardhan Reddy
- Drug Delivery Research Laboratory, Center of Relevance and Excellence in NDDS, Pharmacy Department, Fatehgunj, M.S. University of Baroda, Baroda-390002, Gujarat, India.
| |
Collapse
|
16
|
Song M, Zhang R, Dai Y, Gao F, Chi H, Lv G, Chen B, Wang X. The in vitro inhibition of multidrug resistance by combined nanoparticulate titanium dioxide and UV irradition. Biomaterials 2006; 27:4230-8. [PMID: 16600364 DOI: 10.1016/j.biomaterials.2006.03.021] [Citation(s) in RCA: 64] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/05/2006] [Accepted: 03/14/2006] [Indexed: 10/24/2022]
Abstract
The appearance of drug-resistant (especially, multidrug-resistant (MDR)) tumor cells is a major obstacle to the success of chemotherapy; thus, the development of effective anti-MDR agents plays an important role in the tumor therapy. In this report, the considerable effect of nano-TiO2 and UV illumination on the drug resistance of target cancer cells has been explored, and the fresh evidence from the fluorescence spectroscopy and microscopy as well as electrochemical studies demonstrates the significant enhancement effect of nano-TiO2 to the drug uptake by drug-resistant leukemia cells. Besides, it is also observed that the combination of the nano-TiO2 and UV irradiation with the accompanying anticancer drug daunorubicin could provoke some considerable changes of the cell membrane of the target leukemia cells, which indicates that nano-TiO2 could not only increase the drug accumulation in target cancer cells, but also act as an effective anti-MDR agent to inhibit the relative drug resistance.
Collapse
Affiliation(s)
- Min Song
- State Key Lab of Bioelectronics, Chien-Shiung Wu Laboratory, and Zhongda Hospital, School of Clinic Medical, Southeast University, Nanjing 210096, PR China
| | | | | | | | | | | | | | | |
Collapse
|
17
|
Yi Y, Kim JH, Kang HW, Oh HS, Kim SW, Seo MH. A Polymeric Nanoparticle Consisting of mPEG-PLA-Toco and PLMA-COONa as a Drug Carrier: Improvements in Cellular Uptake and Biodistribution. Pharm Res 2005; 22:200-8. [PMID: 15783067 DOI: 10.1007/s11095-004-1187-1] [Citation(s) in RCA: 37] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
PURPOSE To evaluate a new polymeric nanoparticulate drug delivery formulation that consists of two components: i) an amphiphilic diblock copolymer having tocopherol moiety at the end of the hydrophobic block in which the hydrophobic tocopherol moiety increases stability of hydrophobic core of the nanoparticle in aqueous medium; and ii) a biodegradable copolyester having carboxylate end group that is capable of forming ionic complex with positively charged compounds such as doxorubicin. METHODS A doxourubicin-loaded polymeric nanoparticle (Dox-PNP) was prepared by solvent evaporation method. The entrapment efficiency, size distribution, and in vitro release profile at various pH conditions were characterized. In vitro cellular uptake was investigated by confocal microscopy, flow cytometry, and MTT assay using drug-sensitive and drug-resistant cell lines. Pharmacokinetics and biodistribution were evaluated in rats and tumor-bearing mice. RESULTS Doxorubicin (Dox) was efficiently loaded into the PNP (higher than 95% of entrapment efficiency), and the diameter of Dox-PNP was in the range 20-25 nm with a narrow size distribution. In Vitro study showed that Dox-PNP exhibited higher cellular uptake into both human breast cancer cell (MCF-7) and human uterine cancer cell (MES-SA) than free doxorubicin solution (Free-Dox), especially into drug-resistant cells (MCF-7/ADR and MES-SA/Dx-5). In pharmacokinetics and tissue distribution study, the bioavailability of Dox-PNP calculated from the area under the blood concentration-time curve (AUC) was 69.8 times higher than that of Free-Dox in rats, and Dox-PNP exhibited 2 times higher bioavailability in tumor tissue of tumor-bearing mice. CONCLUSIONS Dox-PNP exhibited enhanced cellular uptake of the drug. In the cytotoxic activity study, this improved cellular uptake was proved to be more advantageous in drug-resistant cell. Dox-PNP exhibited much higher bioavailability in blood plasma and more drug accumulation in tumor tissue than conventional doxorubicin formulation. The results of this study suggest that the PNP system is an advantageous carrier for drug delivery.
Collapse
Affiliation(s)
- Yilwoong Yi
- Parenteral Delivery Research, Samyang R&D Center, Yuseong-Gu, Daejeon 305-717, South Korea
| | | | | | | | | | | |
Collapse
|
18
|
Vauthier C, Dubernet C, Fattal E, Pinto-Alphandary H, Couvreur P. Poly(alkylcyanoacrylates) as biodegradable materials for biomedical applications. Adv Drug Deliv Rev 2003; 55:519-48. [PMID: 12706049 DOI: 10.1016/s0169-409x(03)00041-3] [Citation(s) in RCA: 315] [Impact Index Per Article: 15.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/30/2023]
Abstract
This review considers the use of poly(alkylcyanoacrylates) (PACAs) as biomedical materials. We first present the different aspects of the polymerization of alkylcyanoacrylate monomers and briefly discuss their applications as skin adhesives, surgical glues and embolitic materials. An extensive review of the developments and applications of PACAs as nanoparticles for the delivery of drugs is then given. The methods of preparation of the nanoparticles are presented and considerations concerning the degradation, in vivo distribution, toxicity and cytotoxicity of the nanoparticles are discussed. The different therapeutic applications are presented according to the route of administration of the nanoparticles and include the most recent developments in the field.
Collapse
Affiliation(s)
- Christine Vauthier
- Laboratoire de Physico-chimie, Pharmacotechnie et Biopharmacie, UMR CNRS 8612, Université de Paris XI, 5 Rue Jean Baptiste Clément, 92296 Cedex, Chatenay-Malabry, France.
| | | | | | | | | |
Collapse
|
19
|
Abstract
Numerous investigations have shown that both tissue and cell distribution profiles of anticancer drugs can be controlled by their entrapment in submicronic colloidal systems (nanoparticles). The rationale behind this approach is to increase antitumor efficacy, while reducing systemic side-effects. This review provides an update of tumor targeting with conventional or long-circulating nanoparticles. The in vivo fate of these systems, after intravascular or tumoral administration, is discussed, as well as the mechanism involved in tumor regression. Nanoparticles are also of benefit for the selective delivery of oligonucleotides to tumor cells. Moreover, certain types of nanoparticles showed some interesting capacity to reverse MDR resistance, which is a major problem in chemotherapy. The first experiments, aiming to decorate nanoparticles with molecular ligand for 'active' targeting of cancerous cells, are also discussed here. The last part of this review focus on the application of nanoparticles in imaging for cancer diagnosis.
Collapse
Affiliation(s)
- Irène Brigger
- University of Paris-Sud XI, UMR CNRS 8612, Faculty of Pharmacy, 5 rue J.B. Clément, 92296 Châtenay-Malabry, France
| | | | | |
Collapse
|
20
|
Clarot I, Clédat D, Battu S, Cardot PJ. Chromatographic study of terpene derivatives on porous graphitic carbon stationary phase with beta-cyclodextrin as mobile phase modifier. J Chromatogr A 2000; 903:67-76. [PMID: 11153956 DOI: 10.1016/s0021-9673(00)00907-9] [Citation(s) in RCA: 30] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
Abstract
The stoichiometric coefficients and apparent formation constants (Kf) of alpha-terpineol, thymol, geraniol and linalool complexes with beta-cyclodextrin (beta-CD) were determined using HPLC with a porous graphitic carbon (PGC) chromatographic support. Measurements were performed with four different methanol-water mobile phases. All the terpene derivatives under study form 1:1 guest-CD complexes. Graphs of Kf as a function of the mobile phase composition appeared different from those classically described for RP-C18 and suggest that the PGC stationary phase could play an active role in the complexation process. Solute-CD inclusion and solute-stationary phase interactions may be involved in this specific behavior.
Collapse
Affiliation(s)
- I Clarot
- Laboratoire de Chimie Analytique et de Bromatologie, Université de Limoges, Faculté de Pharmacie, France
| | | | | | | |
Collapse
|